title: Low-dose of thalidomide in the treatment of refractory myeloma.
authors.forename: M
authors.initials: M
authors.lastname: Pini
authors.forename: A
authors.initials: A
authors.lastname: Baraldi
authors.forename: D
authors.initials: D
authors.lastname: Pietrasanta
authors.forename: B
authors.initials: B
authors.lastname: Allione
authors.forename: L
authors.initials: L
authors.lastname: Depaoli
authors.forename: F
authors.initials: F
authors.lastname: Salvi
authors.forename: A
authors.initials: A
authors.lastname: Levis
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide